Low total testosterone is associated with increased risk of incident type 2 diabetes mellitus in men: Results from the Study of Health in Pomerania (SHIP)

Aging Male

Volumn 14, Issue 3, 2011, Pages 168-175

  Schipf, Sabine ^a   Haring, Robin ^a   Friedrich, Nele ^a   Nauck, Matthias ^a   Lau, Katharina ^a   Alte, Dietrich ^a   Stang, Andreas ^b   Völzke, Henry ^a   Wallaschofski, Henri ^a  

^a UNIVERSITY OF GREIFSWALD   (Germany)

^b MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

Author keywords

population based; risk factor; Study of Health in Pomerania; testosterone; Type 2 diabetes mellitus

Indexed keywords

TESTOSTERONE;

ADULT; AGED; ARTICLE; FOLLOW UP; HIGH RISK POPULATION; HUMAN; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; RISK ASSESSMENT; SENSITIVITY ANALYSIS; SMOKING; WAIST CIRCUMFERENCE;

ADULT; AGED; BLOOD GLUCOSE; BODY MASS INDEX; CHOLESTEROL, HDL; CHOLESTEROL, LDL; DIABETES MELLITUS, TYPE 2; FOLLOW-UP STUDIES; GERMANY; HUMANS; INCIDENCE; MALE; MIDDLE AGED; MOTOR ACTIVITY; ODDS RATIO; RISK FACTORS; TESTOSTERONE; WAIST CIRCUMFERENCE;

EID: 80051534845     PISSN: 13685538     EISSN: 14730790     Source Type: Journal    
DOI: 10.3109/13685538.2010.524955     Document Type: Article

References (36)

1. International Diabetes Federation. About Diabetes. 2009. Electronic citation. http://www.idf.org/about-diabetes. Last accessed 5 September 2009.
2. Shaw JE, Chisholm DJ. Epidemiology and prevention of type 2 diabetes and the metabolic syndrome. Med J Aust 2003;179: 379-383. (Pubitemid 37265135)
3. Crandall JP, Knowler WC, Kahn SE, Marrero D, Florez JC, Bray GA, Haffner SM, Hoskin M, Nathan DM. The prevention of type 2 diabetes. Nat Clin Pract Endocrinol Metab 2008;4:382-393. (Pubitemid 351881862)
4. Ding EL, Song Y, Manson JE, Hunter DJ, Lee CC, Rifai N, Buring JE, Gaziano JM, Liu S. Sex Hormone-Binding Globulin and Risk of Type 2 Diabetes in Women and Men. N Engl J Med 2009.
5. Barrett-Connor E, Khaw KT, Yen SS. Endogenous sex hormone levels in older adult men with diabetes mellitus. Am J Epidemiol 1990;132:895-901. (Pubitemid 20363668)
6. Laaksonen DE, Niskanen L, Punnonen K, Nyyssonen K, Tuomainen TP, Valkonen VP, Salonen R, Salonen JT. Testosterone and sex hormone-binding globulin predict the metabolic syndrome and diabetes in middle-aged men. Diabetes Care 2004;27:1036-1041. (Pubitemid 38579762)
7. Ding EL, Song Y, Manson JE, Hunter DJ, Lee CC, Rifai N, et al. Sex hormone-binding globulin and risk of type 2 diabetes in women and men. N Engl J Med 2009;361:1152-1163.
8. Stanworth RD, Kapoor D, Channer KS, Jones TH. Androgen receptor CAG repeat polymorphism is associated with serum testosterone levels, obesity and serum leptin in men with type 2 diabetes. Eur J Endocrinol 2008;159:739-746.
9. Stanworth RD, Jones TH. Testosterone in obesity, metabolic syndrome and type 2 diabetes. Front Horm Res 2009; 3774-3790.
10. Haffner SM, Shaten J, Stern MP, Smith GD, Kuller L. Low levels of sex hormone-binding globulin and testosterone predict the development of non-insulin-dependent diabetes mellitus in men. MRFIT Research Group. Multiple Risk Factor Intervention Trial. Am J Epidemiol 1996;143:889-897. (Pubitemid 26131096)
11. Stellato RK, Feldman HA, Hamdy O, Horton ES, McKinlay JB. Testosterone, sex hormone-binding globulin, and the development of type 2 diabetes in middle-aged men: Prospective results from the Massachusetts male aging study. Diabetes Care 2000;23:490-494. (Pubitemid 30185792)
12. Goodman-Gruen D, Barrett-Connor E. Sex differences in the association of endogenous sex hormone levels and glucose tolerance status in older men and women. Diabetes Care 2000;23:912-918. (Pubitemid 30480017)
13. Svartberg J, Jenssen T, Sundsfjord J, Jorde R. The associations of endogenous testosterone and sex hormone-binding globulin with glycosylated hemoglobin levels, in community dwelling men. The Tromso Study. Diabetes Metab 2004;30: 29-34. (Pubitemid 38418940)
14. Oh JY, Barrett-Connor E, Wedick NM, Wingard DL. Endogenous sex hormones and the development of type 2 diabetes in older men and women: The Rancho Bernardo study. Diabetes Care 2002;25:55-60. (Pubitemid 41070783)
15. Lakshman KM, Bhasin S, Araujo AB. Sex hormone-binding globulin as an independent predictor of incident type 2 diabetes mellitus in men. J Gerontol A Biol Sci Med Sci, 2010;55:503-509.
16. Vikan T, Schirmer H, Njolstad I, Svartberg J. Low testosterone and sex hormone-binding globulin levels and high estradiol levels are independent predictors of type 2 diabetes in men. Eur J Endocrinol 2010;162:747-754.
17. Chen RY, Wittert GA, Andrews GR. Relative androgen deficiency in relation to obesity and metabolic status in older men. Diabetes Obes Metab 2006;8:429-435. (Pubitemid 44349235)
18. Laaksonen DE, Niskanen L, Punnonen K, Nyyssonen K, Tuomainen TP, Valkonen VP, Salonen JT. The metabolic syndrome and smoking in relation to hypogonadism in middle-aged men: A prospective cohort study. J Clin Endocrinol Metab 2005;90:712-719. (Pubitemid 40279184)
19. Haring R, Volzke H, Felix SB, Schipf S, Dorr M, Rosskopf D, Nauck M, Schofl C, Wallaschofski H. Prediction of metabolic syndrome by low serum testosterone levels in men: Results from the study of health in Pomerania. Diabetes 2009;58: 2027-2031.
20. Matsumoto AM, Bremner WJ. Serum testosterone assays - accuracy matters. J Clin Endocrinol Metab 2004;89: 520-524. (Pubitemid 38269852)
21. Miner MM, Sadovsky R. Evolving issues in male hypogonadism: Evaluation, management, and related comorbidities. Cleve Clin J Med 2007;74 (Suppl 3)S38-S46.
22. Bhasin S, Cunningham GR, Hayes FJ, Matsumoto AM, Snyder PJ, Swerdloff RS, Montori VM. Testosterone therapy in men with androgen deficiency syndromes: An Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 2010;95:2536-2559.
23. World Health Organisation. Definition, diagnosis, and classification of diabetes mellitus and its complications: Report of a WHO consultation. Part 1: diagnosis and classification of diabetes mellitus. Geneva: WHO Department of Noncummunicable Disease Surveillance/NCD/NCS. 1999; pp 1-59.
24. Jankowska EA, Biel B, Majda J, Szklarska A, Lopuszanska M, Medras M, Anker SD, Banasiak W, Poole-Wilson PA, Ponikowski P. Anabolic deficiency in men with chronic heart failure: Prevalence and detrimental impact on survival. Circulation 2006;114:1829-1837. (Pubitemid 44673358)
25. Schatzl G, Madersbacher S, Temml C, Krenn-Schinkel K, Nader A, Sregi G, Lapin A, HermannM, Berger P, Marberger M. Serum androgen levels in men: Impact of health status and age. Urology 2003;61:629-633. (Pubitemid 36294204)
26. Carruthers M, Trinick TR, Wheeler MJ. The validity of androgen assays. Aging Male 2007;10:165-172. (Pubitemid 47265838)
27. Greenland S, Pearl J, Robins JM. Causal diagrams for epidemiologic research. Epidemiology 1999;10:37-48. (Pubitemid 29014427)
28. Royston P, Altman DG, Sauerbrei W. Dichotomizing continuous predictors in multiple regression: A bad idea. Stat Med 2006;25:127-141. (Pubitemid 43136953)
29. Veölzke H, Alte D, Schmidt CO, Radke D, Lorbeer R, Friedrich N, et al. Cohort profile: The Study of Health in Pomerania (SHIP). Int J Epidemiol 2010;39:1-14.
30. Melamed S, Shirom A, Toker S, Shapira I. Burnout and risk of type 2 diabetes: A prospective study of apparently healthy employed persons. Psychosom Med 2006;68: 863-869. (Pubitemid 44808711)
31. Svartberg J, von Muhlen D, Sundsfjord J, Jorde R. Waist circumference and testosterone levels in community dwelling men. The Tromso study. Eur J Epidemiol 2004;19:657-663. (Pubitemid 41175133)
32. Farrell JB, Deshmukh A, Baghaie AA. Low testosterone and the association with type 2 diabetes. Diabetes Educ 2008;34: 799-806.
33. Wang C, Catlin DH, Demers LM, Starcevic B, Swerdloff RS. Measurement of total serum testosterone in adult men: Comparison of current laboratory methods versus liquid chromatography-tandem mass spectrometry. J Clin Endocrinol Metab 2004;89:534-543. (Pubitemid 38269854)
34. Araujo AB, O'Donnell AB, Brambilla DJ, Simpson WB, Longcope C, Matsumoto AM, McKinlay JB. Prevalence and incidence of androgen deficiency in middle-aged and older men: Estimates from the Massachusetts Male Aging Study. J Clin Endocrinol Metab 2004;89:5920-5926. (Pubitemid 39628393)
35. Petak SM, Nankin HR, Spark RF, Swerdloff RS, Rodriguez- Rigau LJ. American Association of Clinical Endocrinologists Medical Guidelines for clinical practice for the evaluation and treatment of hypogonadism in adult male patients - 2002 update. Endocr Pract 2002;8:440-456.
36. Kapoor D, Aldred H, Clark S, Channer KS, Jones TH. Clinical and biochemical assessment of hypogonadism in men with type 2 diabetes: Correlations with bioavailable testosterone and visceral adiposity. Diabetes Care 2007;30: 911-917. (Pubitemid 46556586)